Ex vivo Hsp70-activated NK cells in combination with PD-1 inhibition significantly increase overall survival in preclinical models of glioblastoma and lung cancer
Maxim Shevtsov, Emil Pitkin, Alexander Ischenko, Stefan Stangl, William Khachatryan, Oleg Galibin, Stanley Edmond, Dominik Lobinger, Gabriele Multhoff
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
47Zitate
(Scopus)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Ex vivo Hsp70-activated NK cells in combination with PD-1 inhibition significantly increase overall survival in preclinical models of glioblastoma and lung cancer“. Zusammen bilden sie einen einzigartigen Fingerprint.